Literature DB >> 11573796

Automated synthesis of 16alpha-[18F]fluoroestradiol-3,17beta-disulphamate.

J Römer1, F Füchtner, J Steinbach, H Kasch.   

Abstract

After 16alpha-[15F]fluoroestradiol ([18F]FES) has been successfully prepared in an automated module, the synthesis of 16alpha-[18F]fluoroestradiol-3,17beta-disulphamate ([18F]FESDS) is described as a module-assisted one-pot procedure which can provide 10GBq [18F]FESDS with a radiochemical purity better than 99%. The procedure is reliable and reproducible and requires a time of about 90 min. Because of its high sulphatase-inhibitory effect [15F]FESDS is thought to be a new PET tracer to image sites of high sulphatase activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573796     DOI: 10.1016/s0969-8043(00)00339-0

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  4 in total

1.  A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).

Authors:  Lanell M Peterson; Brenda F Kurland; Erin K Schubert; Jeanne M Link; V K Gadi; Jennifer M Specht; Janet F Eary; Peggy Porter; Lalitha K Shankar; David A Mankoff; Hannah M Linden
Journal:  Mol Imaging Biol       Date:  2013-10-30       Impact factor: 3.488

Review 2.  Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomography.

Authors:  Peter Brust; Jörg van den Hoff; Jörg Steinbach
Journal:  Neurosci Bull       Date:  2014-08-29       Impact factor: 5.203

Review 3.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

4.  An in vitro and in vivo evaluation of a reporter gene/probe system hERL/(18)F-FES.

Authors:  Chunxia Qin; Xiaoli Lan; Jiang He; Xiaotian Xia; Yueli Tian; Zhijun Pei; Hui Yuan; Yongxue Zhang
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.